selenomethionine has been researched along with Cognition Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Liu, Q; Ni, J; Shi, Q; Song, G; Wen, L; Zhang, Y; Zhang, Z | 1 |
Chen, C; Chen, Y; Hoffmann, PR; Liu, Q; Ni, JZ; Song, GL; Wu, QY; Zhang, ZH; Zheng, R | 1 |
2 other study(ies) available for selenomethionine and Cognition Disorders
Article | Year |
---|---|
Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Disks Large Homolog 4 Protein; Female; Glutathione; Glycogen Synthase Kinase 3; Guanylate Kinases; Hippocampus; Male; Membrane Proteins; Mice, Transgenic; Neuroglia; Neuroprotective Agents; Phosphorylation; Protein Phosphatase 2; Selenium; Selenomethionine; Synapses; Synaptophysin; tau Proteins | 2014 |
Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Autophagy; Avoidance Learning; Brain; Cells, Cultured; Cognition Disorders; Enzyme Inhibitors; Gene Expression Regulation; Humans; Macrolides; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Neurons; Presenilin-1; Reaction Time; Selenomethionine; tau Proteins | 2017 |